Skip to main content
. 2023 Jun 2;10:807–820. doi: 10.2147/JHC.S408819

Table 3.

Tumor Responses According to the mRECIST Criteria for Different BCLC Stage

Best Response, n (%) BCLC-A (n=3) BCLC-B (n=13) BCLC-C (n=19)
CR 2 3 7
PR 1 8 8
SD 0 1 2
PD 0 1 2
ORR 100% 84.6% 78.9%
DCR 100% 92.3% 89.4%
Conversion to resectable HCC, n (%) 1 (33.3) 3 (23.1) 10 (52.6)

Abbreviations: mRECIST, modified Response Evaluation Criteria in Solid Tumors; BCLC, Barcelona clinic liver cancer; CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; HCC, hepatocellular carcinoma.